Browse by Publication
 | Up a level |
Jump to: 2019
Number of items: 1.
2019
McMurray, John JV;
DeMets, David L;
Inzucchi, Silvio E;
Køber, Lars;
Kosiborod, Mikhail N;
Langkilde, Anna M;
Martinez, Felipe A;
Bengtsson, Olof;
Ponikowski, Piotr;
Sabatine, Marc S;
+53 more...
Sjöstrand, Mikaela;
Solomon, Scott D;
Nicolau, Jose;
Diez, Mirta;
Katova, Tzvetana;
O’Meara, Eileen;
Ge, Junbo;
Belohlavek, Jan;
Schou, Morten;
Böhm, Michael;
Merkely, Bela;
Chopra, Vijay;
Kitakaze, Masahumi;
De Boer, Rudolf;
Drozdz, Jaroslaw;
Tereshchenko, Sergey;
Dukat, Andrej;
Ljungman, Charlotta;
Chiang, Chern‐En;
Petrie, Mark;
Desai, Akshay;
Pham, Vinh Nguyen;
Pfeffer, Marc A;
Pocock, Stuart;
Swedberg, Karl;
Rouleau, Jean L;
Chaturvedi, Nishi;
Ivanovich, Peter;
Levey, Andrew S;
Christ‐Schmidt, Heidi;
Held, Claes;
Varenhorst, Christoph;
Christersson, Christina;
Mann, Johannes;
Holmgren, Pernilla;
Hallberg, Theresa;
Langkilde, AnnaMaria;
Sjöstrand, Mikaela;
Denison, Hans;
Reicher, Barry;
Bengtsson, Olof;
Fox, Ywonne;
Forsby, Mikael;
Alenhag, Eva‐Lena;
Nilsson, Ann;
Kazanowska, Kinga;
Olofsson, Eva Lavik;
Karup, Cathrine;
Ekedahl‐Berggren, Maria;
Klockargård, Anna‐Lena;
Kempe, Karin;
Selvén, Mathilda;
DAPA-HF Committees and Investigators;
(2019)
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF).
European Journal of Heart Failure.
ISSN 1388-9842
DOI: https://doi.org/10.1002/ejhf.1432